Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADPKD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07663773
What this trial is testing

Thyroid Hormones in CKD

Who this might be right for
Chronic Kidney Disease (Stages 4 and 5)
Mario Negri Institute for Pharmacological Research 51
Testing effectiveness (Phase 2)Study completedNCT00286156
What this trial is testing

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Polycystic Kidney Diseases
The Cleveland Clinic 30
Early research (Phase 1)Looking for participantsNCT07228364
What this trial is testing

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
AstraZeneca 40
Large-scale testing (Phase 3)Ended earlyNCT03918447
What this trial is testing

A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON

Who this might be right for
Autosomal Dominant Polycystic KidneyADPKD
Biogen 667
Not applicableStudy completedNCT03948113
What this trial is testing

Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).

Who this might be right for
Polycystic Kidney Diseases
CHU de Reims 17,350
Testing effectiveness (Phase 2)Study completedNCT01210560
What this trial is testing

Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Not applicableStudy completedNCT00784030
What this trial is testing

High Water Intake to Slow Progression of Polycystic Kidney Disease

Who this might be right for
Kidney, Polycystic, Autosomal Dominant
NYU Langone Health 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT06289998
What this trial is testing

Study of Tamibarotene in Patients With ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Rege Nephro Co., Ltd. 70
Large-scale testing (Phase 3)Study completedNCT01280721
What this trial is testing

Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease （ADPKD)
Otsuka Pharmaceutical Co., Ltd. 135
Not applicableEnrolling By InvitationNCT03901521
What this trial is testing

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Weill Medical College of Cornell University 100
Large-scale testing (Phase 3)Study completedNCT02119052
What this trial is testing

Effects of Somatostatin on Liver in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Federico II University 35
Testing effectiveness (Phase 2)Study completedNCT03203642
What this trial is testing

Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD

Who this might be right for
Autosomal Dominant Polycystic KidneyADPKD
Kadmon, a Sanofi Company 80
Post-approval studies (Phase 4)Study completedNCT02494141
What this trial is testing

Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD

Who this might be right for
Polycystic Kidney, Autosomal Dominant
University of Colorado, Denver 68
Early research (Phase 1)Not Yet RecruitingNCT07181265
What this trial is testing

Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jemincare 48
Not applicableStudy completedNCT03493802
What this trial is testing

Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mayo Clinic 18
Post-approval studies (Phase 4)Study completedNCT00414440
What this trial is testing

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Novartis Pharmaceuticals 431
Not applicableStudy completedNCT02322385
What this trial is testing

Clinical Implications of DNA Analysis on ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Kyorin University 80
Large-scale testing (Phase 3)UnknownNCT02055079
What this trial is testing

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Medical University of Vienna 68
Large-scale testing (Phase 3)Study completedNCT00309283
What this trial is testing

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Mario Negri Institute for Pharmacological Research 78
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Next Page